Nuveen’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.35B Buy
11,006,627
+617,704
+6% +$138M 0.64% 20
2025
Q4
$1.78B Sell
10,388,923
-263,544
-2% -$41M 0.47% 27
2025
Q3
$1.43B Buy
10,652,467
+1,449,899
+16% +$154M 0.38% 42
2025
Q2
$896M Buy
9,202,568
+889,722
+11% +$70.6M 0.25% 78
2025
Q1
$604M Buy
8,312,846
+1,995,306
+32% +$157M 0.18% 106
2024
Q4
$456M Sell
6,317,540
-5,890,350
-48% -$447M 0.13% 134
2024
Q3
$997M Sell
12,207,890
-667,770
-5% -$58.1M 0.28% 64
2024
Q2
$1.37B Sell
12,875,660
-2,217,740
-15% -$213M 0.4% 40
2024
Q1
$1.47B Buy
15,093,400
+851,070
+6% +$74.9M 0.44% 38
2023
Q4
$1.12B Buy
14,242,330
+597,590
+4% +$40.7M 0.36% 54
2023
Q3
$855M Buy
13,644,740
+1,948,980
+17% +$128M 0.3% 71
2023
Q2
$752M Buy
11,695,760
+416,540
+4% +$23.5M 0.26% 81
2023
Q1
$598M Sell
11,279,220
-5,117,780
-31% -$251M 0.22% 100
2022
Q4
$689M Buy
16,397,000
+253,740
+2% +$10.6M 0.27% 91
2022
Q3
$591M Sell
16,143,260
-660,520
-4% -$29.4M 0.24% 89
2022
Q2
$716M Sell
16,803,780
-50,050
-0.3% -$2.38M 0.28% 78
2022
Q1
$905M Buy
16,853,830
+752,480
+5% +$43.8M 0.29% 67
2021
Q4
$1.16B Sell
16,101,350
-563,300
-3% -$35.3M 0.34% 55
2021
Q3
$948M Buy
16,664,650
+1,522,910
+10% +$92.6M 0.29% 70
2021
Q2
$985M Buy
15,141,740
+3,174,510
+27% +$200M 0.29% 69
2021
Q1
$712M Buy
11,967,230
+730,690
+7% +$39.8M 0.23% 91
2020
Q4
$531M Sell
11,236,540
-2,732,180
-20% -$115M 0.18% 115
2020
Q3
$463M Sell
13,968,720
-5,133,600
-27% -$177M 0.18% 119
2020
Q2
$618M Sell
19,102,320
-2,021,440
-10% -$55.1M 0.25% 83
2020
Q1
$507M Buy
21,123,760
+5,161,150
+32% +$149M 0.25% 88
2019
Q4
$467M Sell
15,962,610
-11,023,560
-41% -$293M 0.18% 118
2019
Q3
$624M Buy
26,986,170
+1,963,680
+8% +$41.2M 0.25% 81
2019
Q2
$470M Buy
25,022,490
+21,711,310
+656% +$412M 0.19% 105
2019
Q1
$59.3M Buy
3,311,180
+1,886,330
+132% +$31.5M 0.32% 54
2018
Q4
$19.4M Sell
1,424,850
-437,190
-23% -$6.27M 0.12% 278
2018
Q3
$28.2M Buy
1,862,040
+873,270
+88% +$14.9M 0.15% 221
2018
Q2
$17.1M Buy
988,770
+53,550
+6% +$1.03M 0.11% 284
2018
Q1
$19M Sell
935,220
-206,510
-18% -$4.09M 0.12% 253
2017
Q4
$21M Sell
1,141,730
-600,350
-34% -$11.8M 0.13% 225
2017
Q3
$32.2M Buy
1,742,080
+242,710
+16% +$3.94M 0.21% 124
2017
Q2
$21.2M Sell
1,499,370
-850,240
-36% -$12.5M 0.14% 213
2017
Q1
$30.2M Sell
2,349,610
-906,450
-28% -$10.7M 0.18% 134
2016
Q4
$34.4M Sell
3,256,060
-188,390
-5% -$1.91M 0.17% 132
2016
Q3
$32.6M Buy
3,444,450
+222,360
+7% +$2.02M 0.19% 124
2016
Q2
$27.1M Buy
3,222,090
+217,680
+7% +$1.75M 0.17% 150
2016
Q1
$24.8K Buy
3,004,410
+230,070
+8% +$1.67M 0.13% 163
2015
Q4
$22K Sell
2,774,340
-341,710
-11% -$2.57M 0.11% 196
2015
Q3
$20.4K Buy
3,116,050
+209,080
+7% +$1.53M 0.12% 222
2015
Q2
$23.6K Buy
2,906,970
+857,130
+42% +$6.73M 0.13% 215
2015
Q1
$14.4M Buy
2,049,840
+1,806,260
+742% +$14.3M 0.08% 324
2014
Q4
$1.93M Buy
243,580
+53,310
+28% +$413K 0.01% 857
2014
Q3
$1.42M Buy
190,270
+21,330
+13% +$152K 0.01% 969
2014
Q2
$1.14M Sell
168,940
-14,930
-8% -$89.2K 0.01% 1092
2014
Q1
$1.01M Buy
183,870
+22,860
+14% +$121K 0.01% 1135
2013
Q4
$877K Sell
161,010
-43,580
-21% -$229K 0.01% 1153
2013
Q3
$1.05M Buy
204,590
+46,730
+30% +$228K 0.01% 1082
2013
Q2
$700K Buy
+157,860
New +$714K ﹤0.01% 1183

Other funds holding LRCX

Nuveen's LRCX Position: Q1 2026 in Review

Nuveen increased its Lam Research (LRCX) stake by 5.9% in Q1 2026, buying an estimated $138M and bringing the position to 11,006,627 shares worth $2.35B. The position accounts for 0.64% of the portfolio, ranked #20.

Nuveen first reported a position in LRCX in Q2 2013 and has held it in 52 quarters since. 2,633 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Nuveen held 11,006,627 shares of Lam Research worth $2.35B as of Q1 2026.
  • Nuveen bought 617,704 Lam Research shares in Q1 2026, an estimated $138M.
  • Lam Research made up 0.64% of Nuveen's portfolio in Q1 2026, its #20 holding.
  • Nuveen first reported a position in Lam Research in Q2 2013 and has held it in 52 quarters since.
  • 2,633 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.